Millions of Michiganders who rely on Medicaid for weight management medications could face coverage losses in 2026 as part of proposed state budget changes. In this Expert Q&A, Michigan Medicine physicians explain how limiting access to GLP-1 drugs may affect patients and why state lawmakers should reconsider the decision.
Expert Q&A: Michigan Medicaid’s New Limits on GLP-1 Weight Management Medications
Feb. 6, 2026
•
Read time: <5 mins
Share: